The imperative for clinical trial diversity: Perspectives in the context of prostate-specific membrane antigen-targeted imaging

Prostate Cancer Prostatic Dis. 2023 Sep;26(3):511-515. doi: 10.1038/s41391-023-00657-3. Epub 2023 Mar 6.

¹ Harvard Medical School, Boston, MA, USA. haelin_cho@hms.harvard.edu.
² Departments of Radiation Oncology and Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
³ Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Boston, MA, USA.
⁴ Department of Radiation Oncology, Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
⁵ Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

No abstract available

Publication types